Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | DDO | Q99489 | 1/20 | 0.57 |
| ▸ | TPMT | P51580 | 1/20 | 0.56 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29944817 | 1.00 | HCAR2 (1.00) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10401123 | 0.98 | HCAR2 (0.96) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL28695687 | 0.98 | HCAR2 (0.96) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| Hydrazine SCHEMBL27966471 | 0.96 | HCAR2 (0.92) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| Nitrous Acid SCHEMBL28106100 | 0.92 | HCAR2 (0.85) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL51830 | 0.83 | HCAR2 (0.70) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL4196968 | 0.82 | HCAR2 (0.69) | HCAR2TPMTSMYD3MKNK1MKNK2 | |
| Fluoride SCHEMBL21331909 | 0.80 | HCAR2 (0.67) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| Bromide SCHEMBL21332093 | 0.80 | HCAR2 (0.67) | HCAR2KDM4EALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7661020 | 0.80 | HCAR2 (0.67) | HCAR2KDM4EALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-221867613-U | Convenient clear 5-chloronicotinic acid separator | 浙江荣凯科技发展股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118724802-A | Method for separating and purifying 5-chloronicotinic acid from 2-chloronicotinic acid crystallization mother liquor | 浙江荣凯科技发展股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-117683754-A | Nitrilase mutant and application thereof in pesticide synthesis | 浙江工业大学 | 2024-03-12 | — | — | CN | claimed |
| CN-116987064-B | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117299031-A | Separation and purification device and method for preparing 5-chloronicotinic acid | 浙江荣凯科技发展股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-220257411-U | 5-chloronicotinic acid separation and purification device | 浙江荣凯科技发展股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117126158-A | Synthesis method of loniergoline | 江苏汉斯通药业有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-116987064-A | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-113943947-B | Composite film electrode for electrochemical reduction of carbon dioxide and preparation method thereof | 浙江工业大学 | 2022-11-15 | — | — | CN | claimed |
| CN-113943947-A | Composite film electrode for electrochemical reduction of carbon dioxide and preparation method thereof | 浙江工业大学 | 2022-01-18 | — | — | CN | claimed |
| CN-109212051-B | Gas chromatography-mass spectrometry combined method for determining nine trace amounts of halogenated nicotinic acid in drinking water | 丁立平 | 2021-11-19 | — | — | CN | claimed |
| CN-113046734-A | Bivalent palladium complex solution and preparation method and application thereof | 上海天承化学有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-109212051-A | The gas chromatography-mass spectrometry of nine kinds of halogenated niacin of trace in a kind of measurement drinking water | 丁立平 | 2019-01-15 | — | — | CN | claimed |
| WO-2006073361-A9 | NOVEL PYRIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2007-08-02 | — | — | WO | claimed |
| US-5430049-A | Treating hyperproliferative disorders | GAUT ZANE N (US) | 1995-07-04 | — | — | US | claimed |
| CN-121652407-A | Preparation method and application of mixed valence state and Cu/Eu bimetallic MOF material | 烟台大学 | 2026-03-13 | — | — | CN | disclosed |
| US-20250375526-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-12-11 | — | — | US | disclosed |
| US-5364939-A | Chlorinating hydroxy carboxylic acid with phosphorus pentachloride in phosphoroxy chloride | LONZA LTD. (CH) | 1994-11-15 | — | — | US | disclosed |
| WO-1994022868-A1 | 7-AZABICYCLO-[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS | UNIVERSITY OF VIRGINIA (US) | 1994-10-13 | — | — | WO | disclosed |
| US-4093622-A | Pyridine esters of cyclopropane-carboxylic acid | ZOECON CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375526-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | HCAR2 983/4885KDM4E 190/4885ALDH1A1 2776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.